$PTHS
Pelthos Therapeutics Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
$20.26
▲+0.55%+$0.110
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePelthos Therapeutics Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Why is PTHS up today? It is at $20.26 (+0.55%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PTHS spikes, and full due diligence on PTHS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PTHS 14 times in the last 30 days. Create a free account to track $PTHS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PTHS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on PTHS today, peaking at 4.6x its normal volume.
Likely catalystExecutive / Board Change · Shareholder Vote, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Pauls Matthew Director | Sold (automatic/other) | -786 0.02% of company | sold 5.5% | 14K | $17K at $21.00 | Oct 2, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -558 0.01% of company | sold 0.7% | 80K | $12K at $20.72 | Oct 2, 26 |
Greenleaf Peter Director | Sold (automatic/other) | -797 0.02% of company | sold 3.3% | 23K | $17K at $21.17 | Oct 2, 26 |
Greenleaf Peter Director | Sold (automatic/other) | -797 0.02% of company | sold 3.2% | 24K | $21K at $26.00 | Jul 2, 26 |
Pauls Matthew Director | Sold (automatic/other) | -786 0.02% of company | sold 5.2% | 14K | $20K at $26.00 | Jul 2, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -558 0.01% of company | sold 0.7% | 81K | $15K at $26.03 | Jul 2, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -283 | sold 0.3% | 82K | $8K at $27.12 | Jun 15, 26 |
Davis Todd C Director | Bought (open market) | +36K 0.9% of company | added 90% | 76K | $999K at $27.80 | Jun 11, 26 |
Francis Knuettel Ii Officer | Sold (automatic/other) | -14K 0.4% of company | sold 42% | 20K | n/a | May 22, 26 |
Francis Knuettel Ii Officer | Sold (automatic/other) | -2K 0.04% of company | sold 6.6% | 21K | $40K at $26.84 | May 22, 26 |
Friedberg Ezra M Director | Sold (automatic/other) | -144 | sold 0.2% | 82K | $4K at $27.01 | May 14, 26 |
Greenleaf Peter Director | Sold (automatic/other) | -797 0.02% of company | sold 3.1% | 25K | $16K at $20.52 | Apr 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
PTHS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on PTHS today, peaking at 4.6x its normal volume.
PTHS last traded at $20.26, up 0.55% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pelthos Therapeutics Inc. (PTHS) is next expected to report earnings on Thursday, November 12, 2026, about 24 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PTHS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PTHS 14 times in the last 30 days.
PTHS (Pelthos Therapeutics Inc.) trades on XASE, with a market cap of about $77M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PTHS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PTHS discussion
Sign in to ask a question or join the discussion.